Silverback Therapeutics raises $78.5m in oversubscribed Series B financing

This article was originally published here

U.S. Venture Partners (“USVP”) led the round, with participation from new investors including Nextech Invest Ltd., Hunt Investment Group, Pontifax Venture Capital, Colt Ventures LP and NS Investment.

The post Silverback Therapeutics raises $78.5m in oversubscribed Series B financing appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply